These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 14757497)
21. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related]
22. Role of cellulose ether polymers on ibuprofen release from matrix tablets. Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME Drug Dev Ind Pharm; 2005 Aug; 31(7):653-65. PubMed ID: 16207613 [TBL] [Abstract][Full Text] [Related]
23. Binary inclusion complexes of diflunisal with β-cyclodextrin and hydroxypropyl-β-cyclodextrin: Preparation and characterization. Bashir M; Syed HK; Asghar S; Irfan M; Aslam N; Iqbal MS; Khan IU; Shah PA; Khan NR; Ahmad J; Saleem M; Asif M Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2307-2315. PubMed ID: 33832905 [TBL] [Abstract][Full Text] [Related]
24. Preparation and evaluation of taste masked famotidine formulation using drug/beta-cyclodextrin/polymer ternary complexation approach. Patel AR; Vavia PR AAPS PharmSciTech; 2008; 9(2):544-50. PubMed ID: 18431648 [TBL] [Abstract][Full Text] [Related]
25. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances. Srivalli KM; Mishra B AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622 [TBL] [Abstract][Full Text] [Related]
26. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying. Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963 [TBL] [Abstract][Full Text] [Related]
27. Influence of amorphous cyclodextrin derivatives on aceclofenac release from directly compressible tablets. Dahiya S; Pathak K Pharmazie; 2007 Apr; 62(4):278-83. PubMed ID: 17484283 [TBL] [Abstract][Full Text] [Related]
28. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin. Mura P; Faucci MT; Bettinetti GP Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903 [TBL] [Abstract][Full Text] [Related]
29. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization. Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938 [TBL] [Abstract][Full Text] [Related]
30. Influence of water soluble polymers on hydroxypropyl-beta-cyclodextrin complexation of rofecoxib. Singh I; Aboul-Enein HY Pharmazie; 2007 Apr; 62(4):284-6. PubMed ID: 17484284 [TBL] [Abstract][Full Text] [Related]
31. Transdermal lontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes. Doliwa A; Santoyo S; Ygartua P Drug Dev Ind Pharm; 2001 Sep; 27(8):751-8. PubMed ID: 11699826 [TBL] [Abstract][Full Text] [Related]
32. The physicochemical characteristics of freeze-dried scutellarin-cyclodextrin tetracomponent complexes. Cao F; Guo J; Ping Q Drug Dev Ind Pharm; 2005 Sep; 31(8):747-56. PubMed ID: 16221609 [TBL] [Abstract][Full Text] [Related]
33. Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: potential as buccal delivery system. Cappello B; De Rosa G; Giannini L; La Rotonda MI; Mensitieri G; Miro A; Quaglia F; Russo R Int J Pharm; 2006 Aug; 319(1-2):63-70. PubMed ID: 16650700 [TBL] [Abstract][Full Text] [Related]
34. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation. Pokharkar V; Khanna A; Venkatpurwar V; Dhar S; Mandpe L Acta Pharm; 2009 Jun; 59(2):121-32. PubMed ID: 19564138 [TBL] [Abstract][Full Text] [Related]
35. Design and in vitro evaluation of novel sustained-release double-layer tablets of lornoxicam: utility of cyclodextrin and xanthan gum combination. Hamza Yel-S; Aburahma MH AAPS PharmSciTech; 2009; 10(4):1357-67. PubMed ID: 19921543 [TBL] [Abstract][Full Text] [Related]
36. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin. Echezarreta-López M; Torres-Labandeira JJ; Castiñeiras-Seijo L; Santana-Penín L; Vila-Jato JL Eur J Pharm Sci; 2000 Feb; 9(4):381-6. PubMed ID: 10664478 [TBL] [Abstract][Full Text] [Related]
37. Drug/cyclodextrin solid systems in the design of hydrophilic matrices: a strategy to modulate drug delivery rate. Miro A; Quaglia F; Giannini L; Cappello B; La Rotonda MI Curr Drug Deliv; 2006 Oct; 3(4):373-8. PubMed ID: 17076639 [TBL] [Abstract][Full Text] [Related]
38. Preparation and evaluation of piroxicam-HPMCAS solid dispersions for ocular use. Jachowicz R; Czech A Pharm Dev Technol; 2008; 13(6):495-504. PubMed ID: 18720246 [TBL] [Abstract][Full Text] [Related]
39. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Ranpise NS; Kulkarni NS; Mair PD; Ranade AN Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225 [TBL] [Abstract][Full Text] [Related]
40. Detecting and identifying the complexation of nimodipine with hydroxypropyl-beta-cyclodextrin present in tablets by Raman spectroscopy. Yang X; Ke W; Zi P; Liu F; Yu L J Pharm Sci; 2008 Jul; 97(7):2702-19. PubMed ID: 17918724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]